Business
ASX 200 expected to drop lower amid COVID-19 vaccine concerns
The S&P/ASX 200 Index (ASX: XJO) is expected to drop lower this morning, with SPI futures currently pointing to a 0.3% decline at the open.
This decline appears to have been driven by concerns over the AstraZeneca-Oxford University COVID-19 vaccine candidate, AZD1222.
What has happened?
Last week AstraZeneca revealed that its phase three trial data showed that its vaccine candidate was highly effective against COVID-19 with certain dosages.
The data showed that when trial participants were given a half dose, followed by a full dose at least one month apart, the vaccine was 90% effective. Whereas, when given as two full doses at least one month apart, the vaccine showed just 62% efficacy.
Overnight, the pharmaceutical giant…
-
Noosa News24 hours agoCar of missing woman found west of Brisbane
-
Noosa News23 hours agoSunshine Coast police saturate roads and beaches this Easter
-
Noosa News23 hours agoCar discovered in search for missing mother Tayla Spies last seen in rural Queensland two months ago
-
Business22 hours agoHow your ASX shares may be impacted by US tariffs